High Intensity Walking to Reduce Frailty

March 2, 2021 updated by: Margaret Danilovich, Northwestern University
The purpose of this study is to evaluate a physical therapist (PT) led gait training intervention for 100 older adults with pre-frailty or frailty. The goals of this study are To determine the effect of gait training intensity on frailty, mobility, physical functioning, and quality of life, as well as balance and healthcare utilization.

Study Overview

Status

Terminated

Conditions

Detailed Description

Frailty is a leading cause of dependency among older adults, affects up to 60% of older adults, and is associated with an increased risk for falls, hospitalizations, institutionalization, and death. Exercise is the most widely recommended treatment for improving physical function among the frailty, but the optimal type or intensity of exercise is unknown. Walking is a preferred physical activity among older adults, however, there are no clear guidelines on the best intensity of walking to reduce frailty. The specific goal of this project is to compare a high intensity walking (HIW) intervention (70-80% of heart rate maximum) to a moderate intensity walking (MIW) intervention (50-60% of heart rate maximum) for pre-frail or frail older adults to determine the impact on frailty, mobility, balance, quality of life, and healthcare utilization.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Receiving services from CJE SeniorLife
  • Pre-frailty or frailty as determined on the SHARE-FI.
  • Able to ambulate at least 10 feet with moderate assistance (<50% physical assistance) or less. Participants will be able to use their assistive device (e.g. cane or walker) during sessions.
  • > 65 years of age
  • Provision of informed consent and clearance for participation as determined by the Exercise and Screening for You (EASY)

Exclusion Criteria:

  • Uncontrolled cardiovascular, metabolic, renal, or respiratory disease that limits exercise participation (e.g., previous heart attack within 3 months of enrollment or uncontrolled diabetes)
  • Resting blood pressure > 180/110 mmHg.59

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Casual Speed Walking
Self selected pace
Moderate intensity (50-60% of Heart Rate maximum)
Experimental: High Intensity Walking
HIW (70-80% Heart Rate max)
Intense walking activity at an intensity of 70-80% of the maximum heart rate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in frailty as measured by the Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)
Time Frame: Baseline, Week 9, Month 6
Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI) which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity
Baseline, Week 9, Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improved mobility as measured by gait speed
Time Frame: Baseline, Week 9, Month 6
Measures related to overall health and mobility
Baseline, Week 9, Month 6
Improved mobility as measured by 6 Minute Walk Test
Time Frame: Baseline, Week 9, Month 6
Measures related to mobility
Baseline, Week 9, Month 6
Improved mobility as measured by Time Up and Go
Time Frame: Baseline, Week 9, Month 6
Measures related to mobility
Baseline, Week 9, Month 6
Improved physical function on the Short Physical Performance Battery
Time Frame: Baseline, Week 9, Month 6
Provide an overall assessment of functional status and physical performance
Baseline, Week 9, Month 6
Improved balance as measured by the Berg Balance Scale
Time Frame: Baseline, Week 9, Month 6
The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults. Minimum Score 0 to Maximum Score 56. • Score of < 45 indicates individuals may be at greater risk of falling
Baseline, Week 9, Month 6
Monthly self reports of Health Care Utilization
Time Frame: Baseline, Week 9, Month 3, Month 4, Month 5, Month 6
Monthly self-reports of number of falls, number of hospitalizations, and number of emergency room visits
Baseline, Week 9, Month 3, Month 4, Month 5, Month 6
Patient Reported Outcomes Measure Information System (PROMIS) Global Health
Time Frame: Baseline, Week 9, Month 6
assess subjective measures of physical and mental health, pain, and quality of life
Baseline, Week 9, Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2018

Primary Completion (Actual)

February 8, 2021

Study Completion (Actual)

March 2, 2021

Study Registration Dates

First Submitted

October 12, 2018

First Submitted That Met QC Criteria

October 15, 2018

First Posted (Actual)

October 17, 2018

Study Record Updates

Last Update Posted (Actual)

March 4, 2021

Last Update Submitted That Met QC Criteria

March 2, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STU00205686

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on High Intensity Walking

Subscribe